LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

Search

Perrigo Co PLC

Затворен

СекторЗдравеопазване

27.02 2.85

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

26.25

Максимум

27.04

Ключови измерители

By Trading Economics

Приходи

38M

-6.4M

Продажби

-94M

1B

P/E

Средно за сектора

2,570

56.602

EPS

0.6

Дивидентна доходност

4.29

Марж на печалбата

-0.613

Служители

8,379

EBITDA

13M

127M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+30.28% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

4.29%

2.45%

Следващи печалби

1.08.2025 г.

Следваща дата на дивидент

17.06.2025 г.

Следваща дата на екс-дивидент

30.05.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

349M

3.7B

Предишно отваряне

24.17

Предишно затваряне

27.02

Настроения в новините

By Acuity

15%

85%

18 / 382 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bullish Evidence

Perrigo Co PLC Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

28.02.2025 г., 17:42 ч. UTC

Значими двигатели на пазара

Perrigo Shares Jump on FDA's Move to Reclassify Wisconsin Infant-Formula Plant

27.02.2025 г., 23:52 ч. UTC

Печалби

Perrigo Gets Facility Reclassification From FDA as 4Q Profit, Revenue Fall

Сравнение с други в отрасъла

Ценова промяна

Perrigo Co PLC Прогноза

Ценова цел

By TipRanks

30.28% нагоре

12-месечна прогноза

Среден 34.25 USD  30.28%

Висок 42 USD

Нисък 27 USD

Според 4 анализатори от Wall Street, предложили 12-месечна ценова цел за Perrigo Co PLC през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

4 ratings

2

Купи

2

Задържане

0

Продай

Техническа оценка

By Trading Central

25.22 / 26.85Подкрепа & съпротива

Краткосрочен план

Strong Bullish Evidence

Средносрочен план

Strong Bullish Evidence

Дългосрочен план

Bullish Evidence

Настроение

By Acuity

18 / 382 Класиране в Здравеопазване

Настроения в новините

Много силни бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Perrigo Co PLC

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.